福瑞股份(300049) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 was CNY 282,517,472.12, representing a 4.65% increase year-over-year, and a total revenue of CNY 807,001,449.48 for the year-to-date, up 12.23% compared to the same period last year[30]. - The net profit attributable to shareholders for Q3 2023 was CNY 29,345,049.31, a 4.01% increase year-over-year, with a year-to-date net profit of CNY 73,164,076.01, reflecting a 20.41% increase[30]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was CNY 32,694,763.12, up 14.95% year-over-year, with a year-to-date figure of CNY 79,435,211.86, an increase of 28.97%[30]. - The total operating revenue for the current period reached ¥807,001,449.48, an increase of 12.2% compared to ¥719,049,123.81 in the previous period[55]. - Net profit attributable to shareholders of the parent company was ¥73,164,076.01, a rise of 20.4% compared to ¥60,762,606.66 in the same period last year[57]. - Basic earnings per share increased to ¥0.2781 from ¥0.2310, reflecting a growth of 20.4%[57]. Cash Flow - Cash received from operating activities increased by 1960.22% to ¥128,533,882, primarily due to incoming payments from external parties[6]. - The net cash flow from operating activities for the year-to-date was CNY 201,394,785.45, showing a significant increase of 84.76%[30]. - Cash flow from operating activities generated a net amount of ¥201,394,785.45, compared to ¥109,000,962.13 in the previous period, indicating a significant increase[60]. - Cash flow from operations showed a net increase of $62.72 million, contrasting with a decrease of $125.14 million in the previous year[64]. Investments - The company's long-term equity investments increased by 79.29% to ¥108,802,479, attributed to additional investment in Theraclion[6]. - The company plans to acquire a 27.78% stake in Theraclion (Shenzhen) Medical Equipment Co., Ltd. for €1, corresponding to an investment of €1 million, which will increase its ownership to 80%[49]. - The company will participate in the establishment of the Fuying Fund with an investment of ¥20 million and invest ¥10 million in a partnership in Ningbo Meishan Free Trade Port Area[49]. - The company’s cash outflow for investing activities rose by 379.20% to ¥228,868,074, indicating increased investment expenditures[6]. Assets and Liabilities - The total assets at the end of Q3 2023 amounted to CNY 2,580,753,093.40, a 2.30% increase from the end of the previous year[30]. - The equity attributable to shareholders at the end of Q3 2023 was CNY 1,552,111,096.29, reflecting a slight increase of 0.43% compared to the end of the previous year[30]. - The company's total current assets decreased to ¥1,193,010,800.12 from ¥1,230,439,023.04, indicating a decline of about 3.0%[51]. - The total non-current assets increased to ¥1,387,742,293.28 from ¥1,292,300,817.82, reflecting an increase of about 7.4%[51]. Shareholder Information - The number of ordinary shareholders reached 16,595, with the largest shareholder holding 11.31% of the shares[8]. - The company completed its employee stock ownership plan with a total of 1,828,200 shares allocated, representing 0.70% of the total share capital[38]. - The company recognized share-based payment expenses of ¥10,040,400 for the first three quarters of 2023 due to the employee stock ownership plan[49]. Financial Expenses and Tax - The company reported a 93.04% increase in income tax expenses, totaling ¥51,062,618, reflecting higher corporate income tax provisions[6]. - The company's financial expenses decreased by 86.83%, resulting in a net financial income of ¥2,222,974, attributed to exchange rate fluctuations[6]. Cash and Cash Equivalents - As of September 30, 2023, the company's cash and cash equivalents increased to ¥541,927,759.16 from ¥479,210,709.13 at the beginning of the year, reflecting a growth of approximately 13.5%[51]. - Total cash and cash equivalents at the end of the period increased to $541.93 million, up from $347.59 million year-over-year[64]. - The beginning cash and cash equivalents balance was $479.21 million, slightly up from $472.72 million year-over-year[64]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[56].